Zota Health Care — 360° view

Zota Health Care, a company in the Pharmaceuticals industry, reported revenue of ₹199 crore and a net loss of ₹26 crore for the September 2026 quarter.

Zota Health Care (NSE: ZOTA) closed at ₹1,288.00 on 20 Nov 2026, down 22.9% over the past year. Its market capitalisation is ₹4,461 crore.

Share price
₹1,288.00 (20 Nov 2026)
Market cap
₹4,461 Cr (20 Nov 2026)
Revenue
₹199 Cr (September 2026 quarter)
Net profit
₹-26 Cr (September 2026 quarter)
ROCE
-8.47% (FY26)
ROE
-15.0% (FY26)
Book value
₹181 (FY26)
Dividend yield
0.08% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,740.00 / ₹1,022.00 (20 Nov 2026)
1-year return
-22.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ZOTA

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.